Michael D. Berquist

Michael D. Berquist

Auto-generated profile, based on publicly available information

Michael D. Berquist

Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Mail Slot 611, Little Rock, AR 72205, United States of America

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Behavioural Pharmacology
Verified
Journal Article
Open access
MBMichael D. Berquist
Michael D. Berquist
WFWilliam E. Fantegrossi
William E. Fantegrossi
The objectives of this study were to determine alcohol consumption after administration of (R)(-)-2,5-dimethoxy-4-iodoamphetamine (DOI) or naltrexone in Long–Evans rats, and to assess the effectiveness of these treatments based on individual differences in alcohol consumption. Adult male Long–Evans rats (N = 16) were given opportunities to orally self-administer a 20% (v/v) ethanol (EtOH) solution using an intermittent access, two-bottle (vs. tap water) choice procedure in their home cages. EtOH consumption and preference, total fluid consumption and food intake were measured. Last, we assessed the effects of naltrexone (1 mg/kg; subcutaneous) and (R)(-)-DOI (0.1–1 mg/kg; subcutaneous) on EtOH intake and preference using a quartile analysis. Rats showed stable EtOH (20%) intake and preference after 15 EtOH access sessions. Naltrexone produced a transient decrease in EtOH intake, but an inconsistent effect on EtOH preference, whereas DOI dose-dependently reduced EtOH intake and preference for at least 24 h. Subsequent quartile analyses revealed that rats with the highest EtOH intake during the first 60 min of access to EtOH showed greater reductions in EtOH intake and preference after DOI treatment. This is the first report to show that DOI-elicited reductions in EtOH intake and preference in rats depend on baseline EtOH intake, perhaps supporting a ‘baseline dependency’ hypothesis of effectiveness with phenethylamine psychedelics on EtOH consumption. If so, individuals with greater potential to develop severe AUDs may be particularly responsive to the positive motivational changes produced by treatment with psychedelics that target the 5-HT2 receptor family.

1 October 2017 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
MHMichael Hambuchen
Michael Hambuchen
HHHoward P. Hendrickson
Howard P. Hendrickson
MGMelinda G. Gunnell
Melinda G. Gunnell
SMSamantha J. McClenahan
Samantha J. McClenahan
LELaura Ewing
Laura Ewing
SOS. Michael Owens
S. Michael Owens

28 March 2024 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
BPB.J. Parks
B.J. Parks
PSP. Salazar
P. Salazar
LML. Morrison
L. Morrison
MMM.K. McGraw
M.K. McGraw
MGM. Gunnell
M. Gunnell
MBM D Berquist
M D Berquist

1 May 2018 in Neuropharmacology
Verified
Journal Article
Closed access
MBMichael D. Berquist
Michael D. Berquist
WHWilliam S. Hyatt
William S. Hyatt
JBJonathan Bauer-Erickson
Jonathan Bauer-Erickson
BGBrenda M. Gannon
Brenda M. Gannon
ANAndrew P. Norwood
Andrew P. Norwood
WFWilliam E. Fantegrossi
William E. Fantegrossi

17 July 2026 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
MBMichael D. Berquist
Michael D. Berquist
BGBrenda M. Gannon
Brenda M. Gannon
KHKevin M. Honeywell
Kevin M. Honeywell
HSHannah E. Shaw
Hannah E. Shaw
TCTheresa M. Carbonaro
Theresa M. Carbonaro
WFWilliam E. Fantegrossi
William E. Fantegrossi

18 May 2023 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
PDF file
BPBrian Parks
Brian Parks
PSPaloma Salazar
Paloma Salazar
MMMadison McGraw
Madison McGraw
LMLindsey Morrison
Lindsey Morrison
JTJulia Tobacyk
Julia Tobacyk
MBMichael Berquist
Michael Berquist
ID 24021 Poster Board 215 Alcohol (EtOH) use significantly contributes to the three leading causes of death among adolescents: unintentional injuries, suicide, and homicide. Adolescents consume more EtOH per drinking occurrence than adults. Early life adversities (ELA), including prenatal opioid exposure (POE) and postnatal adverse experiences, increase the risk of problematic EtOH use among adolescents. POE is any exposure to opioids during gestation and postnatal adverse experiences include abuse, neglect, or household dysfunction, such as parental substance use disorder. Because they often co-occur and are risk factors for early EtOH use, we investigated the relationship between POE, postnatal adversity, and adolescent EtOH. We also aimed to determine how α-adrenoceptor activity is affected by these ELAs to in turn affect adolescent EtOH intake. To model POE, pregnant rats received 15 mg/kg/day morphine or vehicle via subcutaneous minipumps from gestational day 9 to birth. To model postnatal adversity, we used limited bedding and nesting (LBN) procedures in which dams and litters were restricted to 20% of normal bedding and nesting materials from postnatal day (PD) 3 to 11. LBN increases maternal stress and decreases maternal care quality. Starting on PD 31 or 33, rats were given access to bottles containing either a 20% EtOH (v/v) solution or water under an intermittent-access, two-bottle choice procedures for 24-hour sessions, three days per week for four weeks (12 sessions). Rats received either yohimbine (1 mg/kg; ip) or vehicle 30-min prior to each EtOH access session to determine if pharmacologically-induced sympathomimetic activity enhances the acquisition of EtOH in adolescent rats and to assess for altered α2-adrenoceptor activity in rats that experienced POE and/or LBN. Cortices and brainstems from littermates without EtOH exposure were harvested on either PD 30 or PD 70 and used in radioligand receptor binding assays to quantify α1- and α2-adrenoceptor density. We hypothesized that adolescents with a history of combined POE and LBN (“two-hit” group) will consume more EtOH, have higher brain densities of α1-adrenoceptor, and have lower brain densities of α2-adrenoceptor than adolescents with either condition alone. In general, female rats drank more EtOH than male rats, and EtOH consumption was more affected by treatment condition in females than males. For example, female rats, more so than male rats, in the two-hit treatment group drank more EtOH after administration of yohimbine. Also, in the two-hit group, there was a decrease in EtOH consumption compared to the LBN and control groups within each sex. In our adrenoceptor density study, there was no difference in α1-adrenoceptor expression between males and females and across treatment groups. However, in the female cortex, there was high variability and a main effect of sex in α2-adrenoceptor expression with male expression being greater. Together, these results indicate a complex interaction between ELA, sex, and α-adrenoceptor activity that may support a stress inoculation hypothesis. Support/Funding Information: NIDA 5T32DA022981 ABI/ACRI Grant Award